Drug Profile
D 1367
Latest Information Update: 18 May 1998
Price :
$50
*
At a glance
- Originator Celltech Group
- Class Analgesics; Nonsteroidal anti-inflammatories
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 18 May 1998 Discontinued-I for Pain in United Kingdom (PO)
- 03 Oct 1995 New profile
- 03 Oct 1995 Phase-I clinical trials for Pain in United Kingdom (PO)